Viemed Healthcare, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
5/10
|
31.93 | 57.27 | -44.24% | 28.69 | +11.3% |
| P/S |
|
1.76 | 33.44 | -94.75% |
|
|
| P/BV |
|
2.89 | 4.64 | -37.84% |
|
|
| P/FCF |
|
0 | 42.53 | -100% |
|
|
| Ev/Ebitda |
|
8.52 | -17.68 | -148.21% |
|
|
| Ev/S |
|
1.74 | 22.59 | -92.29% |
|
|
| Ev/FCF |
|
16.67 | 47.55 | -64.94% |
|
|
| E/P |
|
0 | 0.0182 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
20.44 | -14.2 | -243.89% | 20.82 | -1.84% |
| ROE |
|
9.04 | 9.78 | -7.6% |
|
|
| ROA |
|
6.65 | 0.33 | 1913.91% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
5.5 | -26.41 | -120.82% |
|
|
| ROCE |
|
14.3 | 14.5 | -1.39% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.21 | -3.87 | -105.42% | 0.2008 | +4.56% |
| Nеt Debt/Ebitda |
|
-0.0657 | -4.24 | -98.45% |
|
|
| Debt/Ratio |
|
0.0519 | 0.1853 | -71.99% |
|
|
| Debt/Equity |
|
0.2015 | 1.56 | -87.11% |
|
|
| Debt/Net Income |
|
0.7808 | 10.06 | -92.24% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5351 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.235 | -100% |
|
|
| Average dividend growth |
|
0 | 1.41 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.486 | -100% |
|
|
| Average percentage for payments |
|
13.62 | 43.64 | -68.79% |
|
|
| Difference from average difference in sector |
|
-0.5351 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
127.91 | 30.62 | 317.73% | ||
| Growth impulse Ebitda in 5 years |
|
135.29 | -17.42 | -876.64% | ||
| Growth impulse Net Income in 5 years |
|
20.51 | -52.26 | -139.25% | ||
| Growth impulse FCF in 5 years |
|
235.42 | -31.68 | -843.12% | ||
| Growth impulse EPS in 5 years |
|
18.26 | -61.82 | -129.54% |
IP Score
5.5/10
